Masimo supports surge capacity efforts with a range of noninvasive monitoring and ancillary single-use solutions that can help care teams prepare for and manage an influx of patients quickly and efficiently.

Portfolio highlights:

• Surge Capacity Management Support
• Home Monitoring and Telemedicine Solutions
• Infection Control and Prevention Solutions

Rapidly respond to an increase in patient volume:

• Quickly adapt non-clinical spaces into advanced care environments with a range of out-of-the box Pulse CO-Oximeters^® and vital signs monitors
• Remotely monitor all patients at a glance at a centralised view station with Patient SafetyNet™*
  • With Replica™, view and respond to alarms and alerts from a smart phone, regardless of location
• Use Early Warning Scores (EWS), configured per hospital protocol, to quickly assess patient status
• Support patients suffering from pulmonary conditions and respiratory distress with Masimo softFlow^®, nasal high-flow therapy that administers warmed and humidifed respiratory gases through a comfortable nasal cannula

Innovative solutions help care teams minimise transmission risks and increase clinician and patient safety:

Convert to single-patient-use sensors, available in a variety of tetherless and tethered styles.

Masimo supplies a range of advanced home monitoring solutions that help ensure you can monitor with confidence from a distance, including:

• Secure home-based patient management with Masimo SafetyNet™, which combines tetherless pulse oximetry, respiration rate, and temperature monitoring with a remote data capture and surveillance platform
• Compact, hospital-grade portable monitors with supplemental remote monitoring
• Automated remote care that facilitates the collection of physiological data and patient responses, while providing notification and guidance
• Portable spot-check monitoring of SpO₂, pulse rate, and respiration rate with the MightySat^® Rx fingertip pulse oximeter, featuring clinically proven Masimo SET^® technology

In response to blood shortages due to COVID-19, Masimo is offering licenses for rainbow^® noninvasive blood constituent monitoring, including total haemoglobin, SpHb^®, at no additional charge during the coronavirus pandemic:

• SpHb provides real-time visibility to changes, or lack of changes, in haemoglobin between invasive blood samples—and has been shown to help clinicians improve patient blood management**
• Available where rainbow^®-ready devices are already in use

Noninvasively Monitor Methaemoglobin Levels in the Blood

• SpMet^® helps clinicians monitor methaemoglobin levels in the blood and may be an important monitoring tool during inhaled nitric oxide (iNO) therapy, currently being investigated as a potential treatment for lung complications associated with COVID-19